Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
| Previous close | 88.01 |
| Open | 87.00 |
| Bid | 86.38 x 800 |
| Ask | 86.30 x 800 |
| Day's range | 84.71 - 88.37 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,007,522 |
| Market cap | 52.022B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 37.58 |
| EPS (TTM) | 2.30 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.40 |
ZacksFactors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
Investor's Business DailyThis 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss
Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve replacements.
ZacksEdwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Strong performance of SAPIEN 3 Ultra RESILIA platform and sustainable TAVR growth drives Edwards Lifesciences (EW) Q1 revenues.
© 2024 Yahoo. All rights reserved.